date, a total of 10-patients (5 Female, mean age 61 ± 9.5 years) who received both SCS and PNFS for the treatment of their pain were analyzed. At baseline, a mean score of 7.6 ± 1.4 (NRS) was reported which reduced to 2.7 ±1.3 (n = 4.9) at last follow-up (median = 516 days). Data collection and analysis is still ongoing, and updated, new results will be presented. Conclusions Results of this observational case-series so far demonstrate that patients who use PNFS along-with SCS for treatment of chronic pain can achieve significant and clinical meaningful pain relief.

date, a total of 10-patients (5 Female, mean age 61 ± 9.5 years) who received both SCS and PNFS for the treatment of their pain were analyzed. At baseline, a mean score of 7.6 ± 1.4 (NRS) was reported which reduced to 2.7 ±1.3 (n = 4.9) at last follow-up (median = 516 days). Data collection and analysis is still ongoing, and updated, new results will be presented. Conclusions Results of this observational case-series so far demonstrate that patients who use PNFS along-with SCS for treatment of chronic pain can achieve significant and clinical meaningful pain relief.